Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Share-based Compensation (2018 - 2026)

Organogenesis Holdings has reported Share-based Compensation over the past 8 years, most recently at $4.3 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 49.57% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $13.3 million, up 25.71%, while the annual FY2025 figure was $13.3 million, 25.71% up from the prior year.
  • Share-based Compensation for Q4 2025 was $4.3 million at Organogenesis Holdings, up from $3.1 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $4.3 million in Q4 2025 and troughed at $698000.0 in Q1 2021.
  • A 5-year average of $2.2 million and a median of $2.3 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: surged 233.97% in 2021 and later dropped 1.01% in 2025.
  • Year by year, Share-based Compensation stood at $1.1 million in 2021, then skyrocketed by 71.28% to $1.9 million in 2022, then grew by 27.55% to $2.4 million in 2023, then increased by 22.19% to $2.9 million in 2024, then soared by 49.57% to $4.3 million in 2025.
  • Business Quant data shows Share-based Compensation for ORGO at $4.3 million in Q4 2025, $3.1 million in Q3 2025, and $2.5 million in Q2 2025.